Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids

Journal of Controlled Release : Official Journal of the Controlled Release Society
Tetsuo YamagataNicholas A Peppas

Abstract

The objective of this study was to elucidate the mechanisms contributing to oral bioavailability of insulin by poly(methacrylic acid grafted with poly(ethylene glycol)) (P(MAA-g-EG)) hydrogels using the gastric and intestinal fluids from rats. P(MAA-g-EG) hydrogels successfully protected the incorporated insulin from enzymatic degradation by forming interpolymer complexes in the gastric fluid. The hydrogels also showed the insulin protection ability by itself. In the intestinal fluid, P(MAA-g-EG) hydrogels significantly decreased the insulin degradation rate and calcium ion levels, while protein levels was not changed. Insulin protecting effects were dependent on the fraction of the carboxylic group in the polymer networks. Moreover, the insulin degradation inhibitory effect was significantly correlated with Ca2+ deprivation ability of P(MAA-g-EG) hydrogels in the intestinal fluid, implying that the Ca2+ deprivation ability plays an important role in the inhibition of the intestinal enzyme activities. Insulin-loaded P(MAA-g-EG) (ILPs) hydrogels showed a rapid and almost complete insulin release even in the presence of intestinal proteases. These results suggested that the insulin protection ability of the hydrogels contributed ...Continue Reading

References

Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·A Bernkop-Schnürch
Sep 10, 1999·Journal of Pharmaceutical Sciences·A M LowmanN A Peppas
Aug 24, 2001·The Journal of Pharmacy and Pharmacology·V AgarwalM A Khan
Mar 17, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Koji NakamuraAnthony M Lowman
May 19, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mariko MorishitaAnthony M Lowman
Aug 7, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Andreas Bernkop-SchnürchThomas Palmberger
May 24, 2005·International Journal of Pharmaceutics·Yoshinobu AokiKozo Takayama

❮ Previous
Next ❯

Citations

Dec 18, 2008·Pharmaceutical Research·Chien-Chi Lin, Kristi S Anseth
Jan 12, 2013·Pharmaceutical Research·Jing ZhangChunhua Yin
Mar 31, 2009·International Journal of Molecular Sciences·Liefeng ZhangYong Ren
Jul 31, 2012·Therapeutic Delivery·Lamees B AlkayyaliDavid S Jones
Dec 1, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Er-Yuan ChuangHsing-Wen Sung
Jul 23, 2013·Journal of Drug Targeting·Hairui LiLifeng Kang
May 29, 2012·Journal of Drug Targeting·Seung Woo ChungYoungro Byun
Dec 9, 2009·Journal of Drug Targeting·Tin Wui Wong
Mar 23, 2011·Drug Development and Industrial Pharmacy·Raghavendra C MundargiTejraj M Aminabhavi
Dec 29, 2005·Journal of Pharmaceutical Sciences·Takahiro GotoNicholas A Peppas
Sep 19, 2007·Journal of Pharmaceutical Sciences·Anthony TuescaAnthony Lowman
Jun 28, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·William B LiechtyNicholas A Peppas
Jun 15, 2010·Nano Today·Margaret A PhillipsNicholas A Peppas
Nov 11, 2014·Crystal Growth & Design·Jose A GaviraMadeline Torres-Lugo
Dec 20, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Noriyasu KameiKozo Takayama
Aug 30, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Noriyasu KameiKozo Takayama
Feb 12, 2008·International Journal of Pharmaceutics·Nikhil J Kavimandan, Nicholas A Peppas
Dec 21, 2007·International Journal of Pharmaceutics·Koji NakamuraKozo Takayma
Sep 21, 2007·Advanced Drug Delivery Reviews·El-Sayed KhafagyKozo Takayama
May 19, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiang Yuan XiongGuo Xiu Xie
Apr 26, 2007·Macromolecular Bioscience·Sijian HouPeter X Ma
Jan 3, 2013·Journal of Biomedical Materials Research. Part a·Cody A SchoenerNicholas A Peppas
Nov 20, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kiran ChaturvediTejraj M Aminabhavi
Sep 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Guanghui Ma
Feb 13, 2015·Biomacromolecules·Jennifer M KnipeNicholas A Peppas
Jul 2, 2015·Biomaterials·Er-Yuan ChuangHsing-Wen Sung
May 25, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Er-Yuan ChuangHsing-Wen Sung
Mar 5, 2015·Chemical Communications : Chem Comm·Yan LvXiaojun Ma
Oct 25, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Lei LiJuming Yao
May 2, 2018·Biological & Pharmaceutical Bulletin·Yu FukuokaMariko Takeda-Morishita
May 28, 2019·Chemistry : a European Journal·Nicolas G ChablozJames D E T Wilton-Ely
Nov 7, 2013·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Xiaoye GaoXuesi Chen
Aug 8, 2012·Dalton Transactions : an International Journal of Inorganic Chemistry·Jing WangHongwei Song
Jul 10, 2013·Dalton Transactions : an International Journal of Inorganic Chemistry·Jing WangHongwei Song
Mar 22, 2019·Pharmaceutics·Bahman HomayunHyo-Jick Choi
Apr 16, 2021·ACS Biomaterials Science & Engineering·Rolf Bech KjeldsenAnja Boisen
May 3, 2018·Acta Pharmaceutica Sinica. B·Angela M WagnerNicholas A Peppas
May 25, 2012·Langmuir : the ACS Journal of Surfaces and Colloids·Moustafa R K AliMostafa A El-Sayed
Nov 24, 2021·Advanced Healthcare Materials·Angela M GutierrezJ Zach Hilt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.